









Atlas Genet Cytogenet Oncol Haematol. 2008;12(5)  371 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology                         
                         OPEN ACCESS JOURNAL AT INIST-CNRS 
KCNH1 (potassium voltage-gated channel, 
subfamily H (eag-related), member 1) 
Luis A Pardo 
Max-Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075, Göttingen, Germany 
Published in Atlas Database: January 2008 
Online updated version: http://AtlasGeneticsOncology.org/Genes/KCNH1ID41048ch1q32.html  
DOI: 10.4267/2042/38571 
This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. 









450 kb, 11 exons. 
Transcription 
Main RNA species with 9 kb. An alternatively spliced 
variant with 81 additional bp. 
Protein 
Description 
Tetramer consisting of subunits with 969 aminoacids 
each. The protein contains a PAS domain at the N-
terminus, “Channel” domain with typical features of K 
channels (six putatively transmembrane segments and a 
pore loop between fifth and sixth). Large C-terminal 
domain with cyclic-nucleotide-binding domain, 
calmodulin binding site, tetramerizing coiled-coil. The 
sequence has many potential posttranslational 
modification sites, but only glycosylation has been 
reported. 
Expression 
Abundant in many brain regions, virtually absent from 
extracranial tissues. Detected in gastric gland chief 
cells, pancreatic acini, spermatogenic cells, endocervix, 
secretory endometrium, reactive lymph nodes 
(germinal centre), mast cells, macrophages, anterior 
pituitary, adrenal gland. 
Localisation 
Plasma membrane. Abundant in intracellular pools both
in neurons and tumor cells. 
Function 
Voltage-gated potassium channel. 
Homology 
Homologous to the “six-transmembrane, one pore” 
potassium channel superfamily. 
Implicated in 
Sarcomas (71% positivity). 
Disease 
Fibrosarcoma, leiomyosarcoma, liposarcoma, 
malignant fibrous histiocytoma, rhabdomyosarcoma, 
synovial sarcoma. 
Prognosis 
Indicative of worse outcome in liposarcoma. 
Solid epithelial tumors (70% positivity). 
Disease 
Esophageal, gastric, colon, hepatocellular, gallbladder, 
pancreatic, renal cell, transitional, prostate, cervi al, 
endometrial, breast and bronchus carcinoma; 
cystadenocarcinoma of the ovary, thyroid papillary 
carcinoma, basalioma, spinalioma, malignant 
melanoma. 
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